XBAT32 Antibody

What is XBAT32 and why are antibodies against it important for plant research?

XBAT32 is a member of the RING domain-containing ankyrin repeat subfamily of E3 ligases in Arabidopsis thaliana. It has been identified as a positive regulator of lateral root development, with xbat32 mutant plants producing fewer lateral roots than wild-type plants. Interestingly, XBAT32 functions by negatively regulating ethylene biosynthesis through the ubiquitination and subsequent degradation of key ethylene biosynthesis enzymes, namely AMINOCYCLOPROPANE-1-CARBOXYLIC ACID SYNTHASE4 (ACS4) and ACS7 . Antibodies against XBAT32 are valuable tools for studying this regulatory mechanism, as they enable detection of XBAT32 protein levels, localization patterns, and interactions with target proteins.

The significance of XBAT32 antibodies stems from their ability to help researchers elucidate the molecular pathways through which XBAT32 influences root architecture. Loss of XBAT32 leads to increased ethylene production, which suppresses lateral root formation. This hormonal interaction is complex, as auxin treatments only partially rescue the lateral root defect in xbat32 mutants, while complete restoration occurs when auxin treatment is combined with ethylene inhibition . XBAT32 antibodies facilitate the investigation of these intricate hormonal cross-talk mechanisms at the protein level.

How are XBAT32 antibodies typically developed and validated?

Development of XBAT32-specific antibodies typically follows these approaches:

• Peptide-based antibodies: Researchers select unique peptide sequences (usually 15-20 amino acids) from XBAT32 that show minimal homology with related proteins like XBAT34 and XBAT35. These peptides are conjugated to carrier proteins such as KLH (keyhole limpet hemocyanin) and used to immunize rabbits or other animals.

• Recombinant protein antibodies: Full-length XBAT32 or specific domains (like the RING domain or ankyrin repeats) are expressed in bacterial systems, purified, and used as immunogens to generate antibodies that recognize multiple epitopes.

Validation of XBAT32 antibodies must include several critical controls:

• Genetic validation: Testing the antibody against protein extracts from wild-type plants versus xbat32 null mutants. The specific band should be absent or significantly reduced in mutant samples .

• Specificity testing: Confirming that the antibody does not cross-react with related proteins XBAT34 and XBAT35, as the reduced lateral root phenotype is unique to XBAT32 .

• Functional validation: Verifying that the antibody can efficiently immunoprecipitate active XBAT32 that retains its ability to ubiquitinate ACS4 and ACS7 in in vitro assays.

What are the primary applications of XBAT32 antibodies in plant developmental research?

XBAT32 antibodies have several important applications in plant developmental research:

• Western blotting: For quantifying XBAT32 protein levels in wild-type versus mutant plants or under different treatment conditions. This is particularly useful for studying how ethylene antagonists like silver nitrate (AgNO₃) and abscisic acid (ABA) affect XBAT32 expression .

• Immunoprecipitation (IP): For isolating XBAT32 protein complexes to study its interactions with ACS4 and ACS7, which have been confirmed in yeast two-hybrid assays . IP can also identify additional interaction partners involved in lateral root development.

• In vitro ubiquitination assays: XBAT32 antibodies can isolate the protein for use in ubiquitination assays to study its E3 ligase activity on ACS proteins and potentially other substrates .

• Immunohistochemistry: For determining the spatial and temporal expression patterns of XBAT32 during lateral root development, which can provide insights into how XBAT32 regulation varies across different root tissues and developmental stages.

• Co-immunoprecipitation (Co-IP): For confirming protein-protein interactions between XBAT32 and ACS proteins or other potential partners in plant tissues, validating the findings from yeast two-hybrid studies .

How do researchers use XBAT32 antibodies to study ethylene biosynthesis regulation?

Researchers employ XBAT32 antibodies to investigate ethylene biosynthesis regulation through several methodological approaches:

• Quantitative protein analysis: Western blotting with XBAT32 antibodies allows researchers to measure XBAT32 protein levels in response to treatments that affect ethylene production. This helps establish correlations between XBAT32 abundance and ethylene levels.

• Ubiquitination analysis: By immunoprecipitating ACS4 and ACS7 (the enzymes that XBAT32 targets for ubiquitination), researchers can assess how XBAT32 affects the post-translational modification of these key ethylene biosynthesis enzymes .

• Protein stability studies: XBAT32 antibodies facilitate pulse-chase experiments to determine how XBAT32 influences the half-life of ACS proteins. This is critical because XBAT32 appears to negatively regulate ethylene biosynthesis by controlling ACS protein abundance .

• Hormone response analysis: By examining XBAT32 protein levels after treatments with ethylene inhibitors (AgNO₃), ethylene precursors (ACC), or other hormones like ABA, researchers can understand how XBAT32-mediated regulation responds to different hormonal signals .

• Genetic complementation verification: When xbat32 mutants are complemented with XBAT32 variants, antibodies confirm protein expression, helping correlate protein levels with the rescue of the lateral root phenotype.

How can XBAT32 antibodies be used to investigate the relationship between ethylene and lateral root development?

XBAT32 antibodies provide powerful tools for investigating the ethylene-lateral root development relationship:

• Protein expression analysis during root development: Immunolocalization using XBAT32 antibodies can reveal the spatial and temporal expression patterns of XBAT32 during lateral root initiation, primordium formation, and emergence. This helps identify critical developmental stages where XBAT32-mediated regulation of ethylene biosynthesis is most active.

• Ethylene inhibition studies: Researchers can use XBAT32 antibodies to monitor protein levels in plants treated with ethylene antagonists like AgNO₃, which significantly increases lateral root production in xbat32 mutants . This approach helps determine whether these treatments affect XBAT32 expression, stability, or activity.

• Hormone cross-talk analysis: By examining XBAT32 protein levels in plants treated with combinations of auxin and ethylene inhibitors, researchers can investigate the molecular basis for the observation that auxin completely restores wild-type levels of lateral root production in xbat32 mutants when coupled with ethylene inhibition .

• ACS protein regulation: Co-immunoprecipitation with XBAT32 antibodies followed by detection of ACS4 and ACS7 can reveal how these interactions change during lateral root development or in response to hormonal treatments, providing insights into the timing of ACS regulation.

• Proximal versus distal root analysis: XBAT32 antibodies can be used to compare protein expression in different regions of the root, correlating with the observed differences in lateral root formation in proximal versus distal portions of the primary root under various treatments .

What methodologies are recommended for studying XBAT32's E3 ligase activity using specific antibodies?

To study XBAT32's E3 ligase activity using specific antibodies, the following methodological approaches are recommended:

• In vitro ubiquitination assays:

  • Immunoprecipitate XBAT32 from plant tissues using specific antibodies

  • Combine purified XBAT32 with recombinant E1, E2, ubiquitin, ATP, and substrate proteins (ACS4/ACS7)

  • Incubate the reaction mixture and analyze by Western blotting

  • Detect ubiquitinated products using anti-ubiquitin antibodies or antibodies against the substrate

• Substrate stability assays:

  • Treat plants with cycloheximide to inhibit new protein synthesis

  • Collect samples at different time points

  • Use Western blotting with antibodies against ACS4/ACS7 to monitor protein degradation

  • Compare degradation rates between wild-type and xbat32 mutant plants

• Proteasome inhibition studies:

  • Treat plants with proteasome inhibitors (e.g., MG132)

  • Immunoprecipitate ACS proteins

  • Detect ubiquitination using anti-ubiquitin antibodies

  • Compare ubiquitination patterns between wild-type and xbat32 mutants

• Domain function analysis:

  • Generate XBAT32 variants with mutations in the RING domain

  • Express these variants in xbat32 mutant background

  • Use antibodies to confirm expression and immunoprecipitate the variants

  • Test ubiquitination activity against ACS4/ACS7

  • Correlate molecular activity with lateral root phenotypes

• Interaction-dependent ubiquitination:

  • Use XBAT32 antibodies for sequential immunoprecipitation experiments

  • First, immunoprecipitate XBAT32-ACS complexes

  • Then, analyze ubiquitination status of the co-precipitated ACS proteins

  • This determines whether interaction correlates with ubiquitination

How do researchers use XBAT32 antibodies to distinguish between related XBAT family members?

Distinguishing between XBAT32 and related family members (XBAT34, XBAT35) using antibodies requires careful methodological approaches:

• Epitope selection strategy:

  • Researchers select peptide sequences unique to XBAT32 that show minimal homology with XBAT34 and XBAT35

  • Sequence alignment tools identify regions of low conservation among family members

  • These unique regions are used to generate XBAT32-specific antibodies

• Cross-reactivity testing:

  • Express recombinant XBAT32, XBAT34, and XBAT35 proteins

  • Perform Western blotting with the XBAT32 antibody on all three proteins

  • Verify that the antibody only detects XBAT32 and not the related family members

  • This is critical because the reduced lateral root phenotype is unique to XBAT32 among these family members

• Genetic validation:

  • Test the antibody against protein extracts from wild-type plants, xbat32, xbat34, and xbat35 mutants

  • Confirm that signal reduction only occurs in xbat32 mutants

  • This genetic approach provides the strongest evidence for antibody specificity

• Immunoprecipitation specificity:

  • Perform immunoprecipitation from plant extracts using XBAT32 antibodies

  • Analyze the precipitated proteins by mass spectrometry

  • Verify that only XBAT32 (and not XBAT34 or XBAT35) is enriched

  • This confirms the antibody's specificity in complex protein mixtures

• Domain-specific antibodies:

  • Generate antibodies against multiple distinct domains of XBAT32

  • Test each antibody's specificity against family members

  • Use combinations of domain-specific antibodies for confirmation

  • This multi-epitope approach increases confidence in protein identification

What are the best practices for using XBAT32 antibodies in immunolocalization studies of root tissues?

When using XBAT32 antibodies for immunolocalization in root tissues, researchers should follow these best practices:

• Sample preparation optimization:

  • Fix root tissues in 4% paraformaldehyde for 2-4 hours (shorter times for younger roots)

  • Consider vacuum infiltration to ensure complete fixative penetration

  • Use gentle cell wall digestion (1% cellulase/pectolyase) followed by mild detergent permeabilization (0.1-0.2% Triton X-100)

  • This preserves tissue architecture while allowing antibody access

• Antibody validation controls:

  • Include wild-type and xbat32 mutant roots as positive and negative controls

  • Use pre-immune serum at equivalent concentrations to test for non-specific binding

  • Include secondary antibody-only controls to assess background fluorescence

  • These controls ensure signal specificity

• Developmental stage considerations:

  • Classify root samples by developmental stage (e.g., pre-initiation, early primordium, emerged lateral root)

  • Use consistent anatomical landmarks to identify comparable regions across samples

  • This approach allows correlation of XBAT32 localization with specific developmental events

• Co-localization studies:

  • Combine XBAT32 immunolocalization with markers for subcellular compartments

  • Use fluorescently-tagged markers for cell types of interest (e.g., founder cells)

  • Perform double-labeling with antibodies against interacting partners (ACS4/ACS7)

  • This provides context for XBAT32 localization patterns

• Hormone treatment protocols:

  • For studying hormone effects, treat seedlings with precise hormone concentrations

  • Use consistent treatment durations (e.g., 5 days for AgNO₃ or ABA treatments)

  • Process treated and control samples in parallel using identical protocols

  • This approach reveals how hormones affect XBAT32 localization

• Image acquisition parameters:

  • Use consistent microscope settings across all samples

  • Acquire z-stacks to capture the full depth of XBAT32 expression

  • Include both proximal and distal portions of the primary root for comparative analysis

  • This ensures representative and comprehensive visualization of XBAT32 patterns

How can researchers use XBAT32 antibodies to investigate hormone cross-talk in regulating lateral root development?

Investigating hormone cross-talk in lateral root development using XBAT32 antibodies requires sophisticated experimental approaches:

• Combinatorial hormone treatment analysis:

  • Design factorial experiments with multiple hormones (auxin, ethylene inhibitors, ABA)

  • Use XBAT32 antibodies for Western blotting to quantify protein levels under different hormone combinations

  • Correlate XBAT32 protein abundance with lateral root phenotypes

  • This approach can explain observations like the synergistic effect of auxin and ethylene inhibition on restoring lateral root production in xbat32 mutants

• Hormone-dependent protein interactions:

  • Perform co-immunoprecipitation with XBAT32 antibodies after various hormone treatments

  • Analyze co-precipitating proteins by mass spectrometry or Western blotting

  • Identify differentially interacting proteins under different hormonal conditions

  • This reveals how hormone signaling affects XBAT32's interaction network

• Spatiotemporal regulation analysis:

  • Combine immunohistochemistry with reporter lines for hormone signaling pathways

  • Apply 3D reconstruction techniques to visualize XBAT32 expression patterns relative to hormone response domains

  • Compare patterns after treatments with ethylene antagonists (AgNO₃) or ABA

  • This maps XBAT32 activity to specific hormone-responsive cell types

• Substrate targeting dynamics:

  • Immunoprecipitate ACS4 and ACS7

  • Analyze their ubiquitination status under different hormone treatments

  • Compare between wild-type and hormone-treated conditions

  • This determines how hormones influence XBAT32's E3 ligase activity toward specific substrates

• Protein modification profiling:

  • Immunoprecipitate XBAT32 following hormone treatments

  • Analyze post-translational modifications by mass spectrometry

  • Identify modifications that correlate with changes in activity

  • This reveals regulatory mechanisms affecting XBAT32 function in response to hormones

What advanced techniques can be used with XBAT32 antibodies to study protein-protein interactions in vivo?

Advanced techniques for studying XBAT32 protein interactions in vivo include:

• Proximity-dependent labeling:

  • Generate fusion proteins linking XBAT32 to enzymes like BioID or APEX

  • Express these fusions in plants and activate labeling

  • Use XBAT32 antibodies to verify fusion protein expression and functionality

  • Purify biotinylated proteins and identify by mass spectrometry

  • This captures both stable and transient interactions in living plant cells

• Förster Resonance Energy Transfer (FRET):

  • Create fluorescently-tagged XBAT32 and potential interaction partners

  • Use XBAT32 antibodies to verify that tagged proteins retain normal localization and function

  • Measure FRET signals in living cells or fixed tissues

  • This provides spatial information about where interactions occur in the cell

• Bimolecular Fluorescence Complementation (BiFC) with antibody validation:

  • Split a fluorescent protein and fuse halves to XBAT32 and potential partners

  • Express in plants and observe fluorescence reconstitution

  • Use XBAT32 antibodies to confirm expression levels and patterns

  • Compare BiFC signals with endogenous XBAT32 localization

  • This visualizes protein interactions in their native cellular context

• Chemical cross-linking immunoprecipitation (CLIP):

  • Treat plant tissues with cell-permeable cross-linkers

  • Immunoprecipitate XBAT32 complexes using specific antibodies

  • Analyze cross-linked products by mass spectrometry

  • This captures interactions that might be too transient for standard co-IP

• Single-molecule imaging:

  • Use fluorescently-labeled XBAT32 antibodies for super-resolution microscopy

  • Track individual XBAT32 molecules in living cells

  • Analyze co-localization with potential interaction partners

  • This provides dynamic information about interaction kinetics

How can researchers develop quantitative assays for XBAT32-mediated ubiquitination using specific antibodies?

Developing quantitative assays for XBAT32-mediated ubiquitination requires precise methodologies:

• In vitro ubiquitination kinetics:

  • Immunopurify XBAT32 using specific antibodies

  • Set up reactions with varying concentrations of ACS4/ACS7 substrates

  • Sample the reaction at defined time points

  • Quantify ubiquitinated products using fluorescently-labeled ubiquitin

  • Determine kinetic parameters (Km, Vmax) for different substrates

  • This provides quantitative measures of XBAT32's catalytic efficiency

• Ubiquitin chain topology analysis:

  • Perform in vitro ubiquitination assays with immunopurified XBAT32

  • Use linkage-specific antibodies (K48, K63, etc.) to detect different ubiquitin chain types

  • Quantify the relative abundance of each linkage type

  • This reveals the fate of ubiquitinated substrates (degradation vs. non-proteolytic functions)

• ELISA-based ubiquitination assays:

  • Coat plates with ACS4 or ACS7 proteins

  • Add immunopurified XBAT32, E1, E2, and ubiquitin

  • Detect ubiquitinated products using anti-ubiquitin antibodies

  • Measure signal intensity to quantify ubiquitination levels

  • This provides a high-throughput method for quantifying XBAT32 activity

• Fluorescence-based real-time assays:

  • Label ubiquitin with fluorophores that change signal upon conjugation

  • Monitor ubiquitination reactions in real-time using a plate reader

  • Compare reaction rates between wild-type XBAT32 and variants

  • This captures the dynamics of ubiquitination as it occurs

• Substrate-specific degradation assays:

  • Generate fluorescently-tagged ACS4 and ACS7

  • Add immunopurified XBAT32 and assembled ubiquitination machinery

  • Monitor fluorescence decrease as substrates are ubiquitinated and degraded

  • Calculate degradation rates for different substrates

  • This measures the functional outcome of XBAT32-mediated ubiquitination

What are the current methodological challenges in studying XBAT32 post-translational modifications?

Studying XBAT32 post-translational modifications faces several methodological challenges:

• Low endogenous expression levels:

  • XBAT32 is likely expressed at relatively low levels as an E3 ligase

  • Enrichment strategies are necessary before analysis

  • Approaches include:

    • Immunoprecipitation with high-affinity XBAT32 antibodies

    • Transgenic plants expressing tagged XBAT32 under native promoter

    • Tissue-specific isolation from roots

  • These strategies increase detection sensitivity

• Auto-ubiquitination complications:

  • As an E3 ligase, XBAT32 likely undergoes auto-ubiquitination

  • This creates heterogeneous protein populations

  • Methodological solutions include:

    • Using proteasome inhibitors to stabilize ubiquitinated forms

    • Developing antibodies specific to ubiquitinated XBAT32

    • Using catalytically inactive XBAT32 mutants as controls

  • These approaches help distinguish auto-ubiquitination from other modifications

• Distinguishing regulatory modifications:

  • Multiple modifications may occur simultaneously (phosphorylation, SUMOylation, etc.)

  • These may influence each other and affect antibody recognition

  • Advanced approaches include:

    • Sequential immunoprecipitation with different modification-specific antibodies

    • Mass spectrometry analysis with enrichment for specific modifications

    • Site-directed mutagenesis of potential modification sites

  • These methods help untangle complex modification patterns

• Spatial and temporal dynamics:

  • Modifications may be transient or occur in specific cell types

  • Capturing these dynamics requires:

    • Rapid tissue harvesting and processing techniques

    • Cell-type specific isolation methods

    • Time-course experiments with precise synchronization

  • These strategies capture modifications that might otherwise be missed

• Functional significance determination:

  • Correlating modifications with XBAT32 activity is challenging

  • Approaches include:

    • Generating modification-mimicking or modification-resistant XBAT32 variants

    • Expressing these in xbat32 mutants and assessing lateral root phenotypes

    • Measuring effects on in vitro ubiquitination of ACS4/ACS7

  • These functional assays connect modifications to biological outcomes

What are the optimal extraction conditions for preserving XBAT32 protein integrity?

Optimizing extraction conditions for XBAT32 requires careful consideration of buffer components and handling procedures:

• Buffer composition optimization:

  • Base buffer: 50 mM Tris-HCl or HEPES, pH 7.5

  • Salt concentration: 150 mM NaCl (standard) or 100-300 mM (test range)

  • Detergents: 0.5-1% Triton X-100 or 0.1-0.5% NP-40

  • Protease inhibitors: Complete protease inhibitor cocktail

  • Phosphatase inhibitors: 10 mM NaF, 1 mM Na₃VO₄

  • Deubiquitinase inhibitors: 10 mM N-ethylmaleimide

  • Reducing agents: 1-5 mM DTT or 2-10 mM β-mercaptoethanol

  • This comprehensive buffer preserves XBAT32 integrity and modification status

• Proteasome inhibition:

  • Include 10-50 μM MG132 in extraction buffers

  • Pre-treat plants with MG132 for 6-12 hours before extraction

  • This prevents degradation of ubiquitinated forms of XBAT32 or its substrates

• Temperature considerations:

  • Maintain samples at 4°C throughout extraction

  • Pre-chill all buffers and equipment

  • Avoid freeze-thaw cycles of extracts

  • Process samples immediately after extraction

  • These measures prevent proteolytic degradation

• Tissue-specific adjustments:

  • For root tissues: Increase mechanical disruption time

  • For developmental studies: Separate root zones before extraction

  • For interaction studies: Consider gentler detergent concentrations

  • These adjustments optimize extraction from different sample types

• Extraction verification:

  • Test multiple extraction conditions in parallel

  • Evaluate protein integrity by Western blotting with XBAT32 antibodies

  • Check for degradation products or aggregation

  • Select conditions that yield the highest amount of full-length, active XBAT32

What controls and validations are essential when using XBAT32 antibodies in research?

Essential controls and validations for XBAT32 antibody research include:

• Genetic controls:

  • Wild-type plants: Positive control showing normal XBAT32 expression

  • xbat32 knockout mutants: Negative control to confirm antibody specificity

  • XBAT32 overexpression lines: Positive control with enhanced signal

  • XBAT34/XBAT35 single expression lines: Controls for cross-reactivity testing

  • This panel confirms antibody specificity against related family members

• Technical controls for Western blotting:

  • Loading controls: Anti-actin or anti-tubulin to normalize protein loading

  • Recombinant XBAT32 protein: Positive control at known concentration

  • Pre-immune serum: Control for non-specific binding

  • Peptide competition: Pre-incubation with immunizing peptide to block specific binding

  • These verify technical aspects of the Western blotting procedure

• Immunoprecipitation validations:

  • Input sample: Confirms presence of target protein before IP

  • IgG control: Non-specific antibody of same isotype as XBAT32 antibody

  • Flow-through analysis: Confirms efficient depletion of XBAT32 from extract

  • Known interactors: Detection of established partners (ACS4/ACS7) as positive controls

  • These confirm specific and efficient immunoprecipitation

• Functional validation:

  • In vitro ubiquitination assay: Confirm immunoprecipitated XBAT32 retains E3 ligase activity

  • Substrate ubiquitination: Verify ability to ubiquitinate ACS4 and ACS7

  • Mutant complementation: Confirm antibody recognizes functional XBAT32 in complemented plants

  • These ensure the antibody recognizes biologically active XBAT32

• Cross-method validation:

  • Compare results from multiple antibodies targeting different XBAT32 epitopes

  • Verify immunolocalization patterns match fluorescent protein fusions

  • Correlate protein levels from Western blotting with transcript levels from qRT-PCR

  • These provide independent confirmation of antibody-based findings

How can researchers optimize immunohistochemistry protocols for XBAT32 localization in root tissues?

Optimizing immunohistochemistry for XBAT32 localization in root tissues requires attention to several methodological factors:

• Fixation optimization:

  • Test multiple fixatives:

    • 4% paraformaldehyde (standard): 2-4 hours at room temperature

    • 2% paraformaldehyde + 0.1% glutaraldehyde: For better ultrastructural preservation

    • Ethanol-acetic acid (3:1): Alternative for certain epitopes

  • Evaluate each fixation method for:

    • Signal intensity with XBAT32 antibodies

    • Tissue morphology preservation

    • Background fluorescence levels

  • Select the method providing optimal signal-to-noise ratio while maintaining tissue structure

• Antigen retrieval evaluation:

  • Test different antigen retrieval methods:

    • Heat-mediated: Citrate buffer (pH 6.0) or Tris-EDTA (pH 9.0)

    • Enzymatic: Proteinase K or trypsin at varying concentrations

    • No retrieval: As baseline comparison

  • Compare signal intensity and specificity for each method

  • Implement retrieval step if it significantly improves detection without increasing background

• Blocking optimization:

  • Test multiple blocking agents:

    • BSA (1-5%)

    • Normal serum (5-10%) from secondary antibody host species

    • Commercial blocking reagents

    • Combinations of proteins and detergents

  • Evaluate reduction of background without compromising specific signal

  • Select optimal blocking conditions for both sections and whole-mount preparations

• Antibody concentration and incubation parameters:

  • Perform titration of primary antibody (1:100 to 1:2000)

  • Test different incubation times and temperatures:

    • 1-2 hours at room temperature

    • Overnight at 4°C

    • 48-72 hours at 4°C for whole-mount preparations

  • Compare signal-to-noise ratio for each condition

  • Select parameters providing robust detection with minimal background

• Detection system selection:

  • Compare different visualization methods:

    • Direct fluorophore-conjugated secondary antibodies

    • Biotin-streptavidin amplification systems

    • Tyramide signal amplification for low abundance targets

  • Evaluate sensitivity, specificity, and signal stability

  • Choose system appropriate for XBAT32 abundance in the tissue of interest

• Tissue-specific protocol modifications:

  • For lateral root primordia:

    • Extend permeabilization time

    • Use gentler handling procedures

    • Consider clearing methods for whole-mount imaging

  • For proximal versus distal root segments:

    • Adjust fixation times based on tissue age and lignification

    • Modify enzyme concentrations for cell wall digestion

  • These adjustments account for differences in tissue properties along the root

What are the best approaches for quantifying XBAT32 protein levels in response to hormone treatments?

Quantifying XBAT32 protein levels in response to hormone treatments requires reliable and sensitive methodologies: